busulfan has been researched along with Kidney Failure, Chronic in 3 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with multiple myeloma (MM) and chronic renal failure have generally been excluded from myeloablative therapy programs followed by hematopoietic stem cell support because of the potential increase in transplant-related morbidity and mortality." | 1.31 | Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. ( Benni, M; Cavo, M; Motta, MR; Rizzi, S; Ronconi, S; Tosi, P; Tura, S; Zamagni, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, K | 1 |
| Ashizawa, M | 1 |
| Toda, Y | 1 |
| Ikeda, T | 1 |
| Kawaguchi, SI | 1 |
| Ito, S | 1 |
| Ochi, SI | 1 |
| Nagayama, T | 1 |
| Mashima, K | 1 |
| Umino, K | 1 |
| Minakata, D | 1 |
| Nakano, H | 1 |
| Yamasaki, R | 1 |
| Yamamoto, C | 1 |
| Hatano, K | 1 |
| Fujiwara, SI | 1 |
| Sato, K | 1 |
| Oh, I | 1 |
| Ohmine, K | 1 |
| Muroi, K | 1 |
| Matsumoto, K | 1 |
| Kanda, Y | 1 |
| Ullery, LL | 1 |
| Gibbs, JP | 1 |
| Ames, GW | 1 |
| Senecal, FM | 1 |
| Slattery, JT | 1 |
| Tosi, P | 1 |
| Zamagni, E | 1 |
| Ronconi, S | 1 |
| Benni, M | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Tura, S | 1 |
| Cavo, M | 1 |
3 other studies available for busulfan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease.
Topics: Busulfan; Humans; Kidney Failure, Chronic; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Renal | 2020 |
Busulfan clearance in renal failure and hemodialysis.
Topics: Administration, Oral; Biological Availability; Blood Transfusion, Autologous; Busulfan; Hematopoieti | 2000 |
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; | 2000 |